All patients (18 years old of greater) who underwent surgical resection for IPMN (including low-, high-grade dysplasia, or invasive carcinoma) between July 1, 2015 and July 1, 2025.
You may not be if
Patients with concomitant pancreatic ductal adenocarcinoma (PDAC)
